DSM-Firmenich Could Keep Minority Stake in Vitamins, Animal-Nutrition Businesses -- Market Talk

Dow Jones

2025/12/30

0756 GMT - DSM-Firmenich's failure to sell its vitamins and animal-nutrition businesses by year-end indicates difficult discussions with private-equity buyers, Berenberg analyst Sebastian Bray writes. Any deal is now likely to result in DSM keeping a roughly 35% stake in the businesses, which could still boost the company's share price, Bray says. "Even if DSM-Firmenich's remaining stake proves difficult to monetize, we suspect the market reaction will be to sigh with relief that the level of volatility associated with the business has been reduced," he says. Shares closed Monday at 69.02 euros and have fallen 29% over the year to date. (ian.walker@wsj.com)

(END) Dow Jones Newswires

December 30, 2025 02:56 ET (07:56 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2595076789"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2595076789\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2595076789?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-30 15:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595076789","market":"hk","top_or_hot":-1,"title":"DSM-Firmenich Could Keep Minority Stake in Vitamins, Animal-Nutrition Businesses -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0756 GMT - DSM-Firmenich's failure to sell its vitamins and animal-nutrition businesses by year-end indicates difficult discussions with private-equity buyers, Berenberg analyst Sebastian Bray writes. Any deal is now likely to result in DSM keeping a roughly 35% stake in the businesses, which could still boost the company's share price, Bray says. \"Even if DSM-Firmenich's remaining stake proves difficult to monetize, we suspect the market reaction will be to sigh with relief that the level of volatility associated with the business has been reduced,\" he says. Shares closed Monday at 69.02 euros and have fallen 29% over the year to date. (ian.walker@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 30, 2025 02:56 ET (07:56 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DSM-Firmenich Could Keep Minority Stake in Vitamins, Animal-Nutrition Businesses -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDSM-Firmenich Could Keep Minority Stake in Vitamins, Animal-Nutrition Businesses -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-12-30 15:56</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0756 GMT - DSM-Firmenich's failure to sell its vitamins and animal-nutrition businesses by year-end indicates difficult discussions with private-equity buyers, Berenberg analyst Sebastian Bray writes. Any deal is now likely to result in DSM keeping a roughly 35% stake in the businesses, which could still boost the company's share price, Bray says. \"Even if DSM-Firmenich's remaining stake proves difficult to monetize, we suspect the market reaction will be to sigh with relief that the level of volatility associated with the business has been reduced,\" he says. Shares closed Monday at 69.02 euros and have fallen 29% over the year to date. (ian.walker@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 30, 2025 02:56 ET (07:56 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DSM","symbol_name":"Dreyfus Strategic Municipal Bond","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2595076789","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595076789","pubTimestamp":1767081360,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0756 GMT - DSM-Firmenich's failure to sell its vitamins and animal-nutrition businesses by year-end indicates difficult discussions with private-equity buyers, Berenberg analyst Sebastian Bray writes. Any deal is now likely to result in DSM keeping a roughly 35% stake in the businesses, which could still boost the company's share price, Bray says. \"Even if DSM-Firmenich's remaining stake proves difficult to monetize, we suspect the market reaction will be to sigh with relief that the level of volatility associated with the business has been reduced,\" he says. Shares closed Monday at 69.02 euros and have fallen 29% over the year to date. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DSM":"Dreyfus Strategic Municipal Bond"},"translate_title":"帝斯曼芬美意可能保留维生素和动物营养业务的少数股权——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DSM":1.5},"content_text":"0756 GMT - DSM-Firmenich's failure to sell its vitamins and animal-nutrition businesses by year-end indicates difficult discussions with private-equity buyers, Berenberg analyst Sebastian Bray writes. Any deal is now likely to result in DSM keeping a roughly 35% stake in the businesses, which could still boost the company's share price, Bray says. \"Even if DSM-Firmenich's remaining stake proves difficult to monetize, we suspect the market reaction will be to sigh with relief that the level of volatility associated with the business has been reduced,\" he says. Shares closed Monday at 69.02 euros and have fallen 29% over the year to date. (ian.walker@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 30, 2025 02:56 ET (07:56 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}